Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Report from Annual general meeting of XVIVO Perfusion AB (publ)

The following resolutions were amongst those adopted at XVIVO Perfusion’s Annual General Meeting held on April 27, 2018: • No dividend will be paid for the financial year 2017. • Gösta Johannesson, Erik von Schenk, Camilla Öberg and Folke Nilsson were re-elected as members of the Board, Yvonne Mårtensson and Alan Raffensperger were elected as new members of the Board and Gösta Johannesson was elected Chairman of the Board, all in accordance with the proposal of the Election Committee. • Remuneration totaling SEK 1,035,000 shall be paid to members of the Board: SEK 205,000 to the

PDMR transactions in Lifco

During the past week, seven PDMRs (Persons Discharging Managerial Responsibilities) have reported purchases of Lifco shares including the CEO and Director Fredrik Karlsson who has acquired 50,000 Class B shares. Other Directors of the Board who have purchased shares are Ulrika Dellby 5,000 Class B shares, Annika Espander Jansson 1,000 Class B shares and Gabriel Danielsson 500 Class B shares. Among other PDMRs controller Mattias Israelsson has acquired 400 Class B shares, head of M&A Ingvar Ljungkvist 13,000 Class B shares and Deputy CEO Per Waldemarson 5,000 Class B shares. The

Nordstjernan publishes supplement to offer document regarding its mandatory bid to the shareholders in Swedol

The offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, and no acceptance forms will be accepted from or on behalf of shareholders in, Australia, Hong Kong, Japan, Canada, New Zeeland, South Africa or the USA, or any other jurisdiction where making the offer, the distribution of this press release or acceptance of the offer would be in conflict with any applicable law or regulation or would require any additional offer document or registration or other measures in addition to those required under Swedish law.On April 16, 2018,

KONE Corporation: Managers' Transactions

KONE Corporation, managers' transactions, April 27, 2018, at 3.30 p.m. EEST____________________________________________ Person subject to the notification requirementName: Security Trading OyPosition: Closely associated person(X) Legal person (1):Person Discharging Managerial Responsibilities In IssuerName: Herlin, AnttiPosition: Member of the Board Issuer: KONE CORPORATIONLEI: 2138001CNF45JP5XZK38 Notification type: INITIAL NOTIFICATIONReference number: 2138001CNF45JP5XZK38_20180427145002_2____________________________________________ Transaction date: 2018-

KONE Corporation: Managers' Transactions

KONE Corporation, managers' transactions, April 27, 2018, at 3.30 p.m. EEST ____________________________________________ Person subject to the notification requirementName: Security Trading OyPosition: Closely associated person(X) Legal person (1):Person Discharging Managerial Responsibilities In IssuerName: Herlin, AnttiPosition: Member of the Board Issuer: KONE CORPORATIONLEI: 2138001CNF45JP5XZK38 Notification type: INITIAL NOTIFICATIONReference number: 2138001CNF45JP5XZK38_20180427144612_3____________________________________________ Transaction date:

The Drug Committee of Ministry of Health, Labour and Welfare in Japan has accepted a 2-year extension of market exclusivity of Lexapro®

· A two-year extension of the reexamination period by the Japanese Ministry of Health, Labour and Welfare (MHLW) has been discussed and accepted in the First Committee on Drug of MHLW · The acceptance is based on the fact that clinical development on pediatrics will be conducted in order to meet the unmet needs of depression in pediatrics · Japanese anti-depressant market was valued at approximately DKK 9 billion in 2017 Valby, Denmark, 27 April 2018 - H. Lundbeck A/S (Lundbeck) today announced that Lexapro® (escitalopram oxalate), which is distributed by Mochida Pharmaceutical Co.,

NPRO: INVITATION TO PRESENTATION OF FIRST QUARTER 2018

Norwegian Property ASA (OSE: NPRO, NPRO.OL) releases its first quarter results for 2018 on Friday 4 May 2018, and we are pleased to invite investors, analysts and media to a presentation of the results. The presentation will be held in Norwegian only, and it will be held by Bent Oustad (CEO) and Haavard Rønning (CFO).  Date: Friday 4 May 2018Time: 08:30 a.m. Central European TimeLocation: Restaurant in 5th floor in Kaibygg I, entrance from Bryggegata 3 at Aker Brygge in Oslo, Norway  The presentation will also be broadcasted live via webcast. The webcast may be followed from: http:

Tecnotree Corporation’s  Auditor’s Report

Tecnotree CorporationStock Exchange Release27 April, 2018 at 15:30Auditor’s Report To the Annual General Meeting of Tecnotree Corporation Report on the Audit of the Financial Statements Opinion We have audited the financial statements of Tecnotree Corporation (business identity code 1651577-0) for the year ended 31 December, 2017. The financial statements comprise the consolidated balance sheet, income statement, statement of comprehensive income, statement of changes in equity, statement of cash flows and notes, including a summary of significant accounting policies, as

Cimco Marine AB (publ) has been awarded the “Best industrial Exporter IPO Sweden 2017 Award” by CFI.co

Ängelholm 2018-04-27 Cimco Marine AB (publ) which produces the world's first diesel engine in the higher power ranges and is listed on Nasdaq First North, has been awarded the "Best Industrial Exporter IPO Sweden 2017 Award". The prize is awarded annually by London-based CFI.co, which monitors business and economics from a global perspective.Summary of jury's motivation: • Cimco Marine has developed the world's first diesel engines with high power. • The development of OXE Diesel represents a marine technical breakthrough. • The development of OXE Diesel is in line with NATO's “

Axactor AB - Invitation to presentation of Q1 2018 results

Axactor AB will present the Q1 results 2018 on Thursday 3rd of May 2018.The presentation will take place at Høyres Hus, Stortingsgaten 20, Oslo at 08.30. Light breakfast is served from 08.00.The presentation will be held by CEO Endre Rangnes and CFO Johnny Tsolis.For practical reasons we ask those interested in attending the presentation to please register by email to kjersti.langness@axactor.com within 10.00 on Wednesday 2nd of May 2018. Oslo, 27th April 2018

Tecnotree’s Annual Report and the Corporate Governance Statement 2017

Tecnotree CorporationStock Exchange Release27 April, 2018 at 15:00Tecnotree’s Annual Report and the Corporate Governance Statement 2017 are published.The Annual Report includes the Financial Statements 2017 and the Board of Directors’ Report.Tecnotree’s Corporate Governance Statement 2017 was published separately from the Board of Directors’ Report in Finnish and in English on the company’s website www.tecnotree.com/Investors and it is also available in the Annual Report 2017. The online report or parts of it are printable in PDF-format at the online report site.TECNOTREE

Ferronordic’s board of directors has resolved on an obligatory redemption of all remaining preference shares

Press Release Stockholm, 27 April 2018In accordance with its previously announced intention, the board of Ferronordic Machines AB (publ) (“Ferronordic” or the “company”) has decided to reduce the company’s share capital by approx. SEK 5,958 by redemption of all remaining 66,728 A-preference shares in the company (“preference shares”). The total redemption price amounts to approx. 81 million. Following the redemption, Ferronordic will no longer have any preference shares outstanding. Consequently, the preference shares will also be delisted from Nasdaq First North. According to the

PAXMAN publishes Annual Report for 2017

PAXMAN hereby publishes its Annual Report for the financial year 2017.The Annual Report is attached to this press release, and may also be downloaded from the company’s website http://www.paxman.se/investor-centre/financial-information/?lang=en.  The attached document contains a condensed version of the complete Swedish annual report “Årsredovisning 2017”. The Swedish version is also available in the printed form and can be ordered from eva.jonasson@paxman.se. The Annual Report has been produced in cooperation with PAXMAN’s IR-partner Honeybadger, http://www.hbadger.com.

Interim report January-March 2018

January-March 2018• Net sales for the first quarter amounted to SEK 3,173 million (3,315).• Organic growth was a negative 6 per cent (pos: 10).• Operating profit amounted to SEK 255 million (273), corresponding to an operating margin of 8.0 per cent (8.2).• Currency losses had an impact of approximately SEK 15 million on the Group’s operating profit, of which a positive SEK 5 million in translation effects and a negative SEK 20 million in transaction effects.• Profit after tax amounted to SEK 193 million (205), corresponding to earnings per share after dilution of SEK 1.14 (1.22).

Amendment: Resolutions from Annual General Meeting in NeuroVive Pharmaceutical AB (publ)

Lund, Sweden, 27 April 2018 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) (“NeuroVive”) today on 27 April 2018 held its Annual General Meeting (AGM). A summary of the resolutions follows. All resolutions were passed with the required majority.Approval of profit and loss accounts and balance sheets, and discharge from liability of the board members and the managing directorThe profit and loss account and balance sheets were approved, and the managing director and the board members were discharged from liability with respect to their respective management of the

#18-735 The Royal Bank of Scotland plc will change name

As from April 30, 2018, The Royal Bank of Scotland plc will change its name according to attached notice to holders sent on March 22 and April 5.Old name: The Royal Bank of Scotland New name: NatWest Markets plc For more details see attached files. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se Nordic Growth Market NGM AB About NGM Nordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of

#18-734 Listing of Knock out warrants issued by BNP Paribas Issuance B.V.

As from April 30, 2018, 2 Knock out warrants issued by BNP Paribas Issuance B.V. will be listed on ETP Sweden and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Sweden AB.Issuer: BNP Paribas Issuance B.V. Type of security: Knock out warrants, open ended Execution: Automatic cash settlement Term: As from April 30, 2018 and forward or until time for knock out event Market Maker: BNP Paribas Arbitrage SNC Underlying: DAX 30 Index Current values of strike and barrier can be found at: [ NGM Market Data Web - KnockOutWarrants ]

#18-733 Listing of Turbo warrants issued by BNP Paribas Issuance B.V.

As from April 30, 2018, 4 Turbo warrants issued by BNP Paribas Issuance B.V. will be listed on ETP Sweden and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Sweden AB.Issuer: BNP Paribas Issuance B.V. Type of security: Call and put Turbo warrants of European type Execution: Automatic cash settlement Term: As from April 30, 2018 to expiry date Market Maker: BNP Paribas Arbitrage SNC Underlying: DAX 30 Index For more details see attached file. For further information concerning this NGM notice please contact: Listing on

#18-732 Listing of Knock out warrants issued by Commerzbank AG

As from April 30, 2018, 6 Knock out warrants issued by Commerzbank AG will be listed on ETP Sweden and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Sweden AB.Issuer: Commerzbank AG Type of security: Knock out warrants, open ended Execution: Automatic cash settlement Term: As from April 30, 2018 and forward or until time for knock out event Market Maker: Commerzbank AG Underlying: DAX 30 Index OMXS30 index Current values of strike and barrier can be found at: [ NGM Market Data Web - KnockOutWarrants ] 

KONE Corporation: Managers' Transactions

KONE Corporation, managers' transactions, April 27, 2018, at 2.45 p.m. EEST ____________________________________________Person subject to the notification requirementName: JOHNSON, WILLIAMPosition: Other senior managerIssuer: KONE CORPORATIONLEI: 2138001CNF45JP5XZK38Notification type: INITIAL NOTIFICATIONReference number: 2138001CNF45JP5XZK38_20180427104902_3____________________________________________Transaction date: 2018-04-25Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI0009013403Nature of the transaction: DISPOSALTransaction details(1):

#18-731 Listing of Knock out warrants issued by Commerzbank AG

As from April 30, 2018, 4 Knock out warrants issued by Commerzbank AG will be listed on ETP Finland and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Finland Oy.Issuer: Commerzbank AG Type of security: Knock out warrants, open ended Execution: Automatic cash settlement Term: As from April 30, 2018 and forward or until time for knock out event Market Maker: Commerzbank AG Underlying: DAX 30 Index Current values of strike and barrier can be found at: [ NGM Market Data Web - KnockOutWarrants ] 

#18-730 Listing of Turbo warrant issued by Commerzbank AG

As from April 30, 2018, 1 Turbo warrant issued by Commerzbank AG will be listed on ETP Finland and will be included on the list for Knock-Outs. The instrument will be registered at Euroclear Finland Oy.Issuer: Commerzbank AG Type of security: Call Turbo warrant of European type Execution: Automatic cash settlement Term: As from April 30, 2018 to expiry date Market Maker: Commerzbank AG Underlying: DAX 30 Index For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se

#18-729 Listing of Turbo warrants issued by Commerzbank AG

As from April 30, 2018, 4 Turbo warrants issued by Commerzbank AG will be listed on ETP Sweden and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Sweden AB.Issuer: Commerzbank AG Type of security: Call Turbo warrants of European type Execution: Automatic cash settlement Term: As from April 30, 2018 to expiry date Market Maker: Commerzbank AG Underlying: DAX 30 Index OMXS30 index For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at

AZ: positive CHMP for Tagrisso first-line nsclc

27 April 2018 12:30 BST    TAGRISSO RECEIVES POSITIVE EU CHMP OPINION FOR 1ST-LINE TREATMENT OF EGFR-MUTATED NON-SMALL CELL LUNG CANCER     Recommendation based on FLAURA trial data showing unprecedented median progression-free survival of 18.9 months for Tagrisso versus 10.2 months compared with current standard of care     The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion, recommending a change to the terms of the Marketing Authorisation for Tagrisso (osimertinib) to include the 1st-line treatment of

There are no items matching the current filter
There are no more items matching the current filter
Back to top